J0743

Category

J. Drugs administered other than oral method

CMS HCPCS quarterly update

These sit next to J0743 in the CMS Level II file. All J codes

• J0738Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
• J0739Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
• J0740Injection, cidofovir, 375 mg
• J0741Injection, cabotegravir and rilpivirine, 2mg/3mg
• J0742Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
• J0744Injection, ciprofloxacin for intravenous infusion, 200 mg
• J0745Injection, codeine phosphate, per 30 mg
• J0750Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
• J0751Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
• J0752Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)

Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.